Intrinsic Value of S&P & Nasdaq Contact Us

Fresenius Medical Care AG & Co. KGaA FMS NYSE

NYSE • Healthcare • Medical - Care Facilities • DE • USD

SharesGrow Score
68/100
3/7 Pass
SharesGrow Intrinsic Value
$92.95
+300.5%
Analyst Price Target
$28.00
+20.6%

Fresenius Medical Care AG & Co. KGaA (FMS) reported total assets of $31B and total liabilities of $16.72B for quarter ending 2025-12-31, resulting in total equity of $14.28B.

The company held $1.6B in cash and short-term investments. Total debt stood at $10.8B, with net debt of $9.2B. The Debt-to-Equity (D/E) ratio was 0.76 (moderate).

Current ratio is 1.26, suggesting adequate short-term liquidity.

Criteria supported by this page:

  • HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (59/100) — Total assets $31B and equity $14.28B support the company's competitive scale
  • VALUE (83/100) — Debt-to-Equity 0.76 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 68/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
68/100
SG Score
View full scorecard →
VALUE
83/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
59/100
Proven by this page
GROWTH
73/100
→ Income
~
INCOME
45/100
→ Income
Fresenius Medical Care AG & Co. KGaA Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $31B$30.89B$31.29B$32.74B
Total Liabilities $16.72B$16.98B$16.96B$17.23B
Total Debt $10.8B$10.47B$11.02B$10.82B
Cash & Investments $1.6B$1.26B$2.19B$1.49B
Total Stockholders Equity $14.28B$12.95B$13.27B$14.37B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message